Premium
Karyopharm Therapeutics Inc (KPTI)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | Mr. Stuart PoultonExec. VP & Chief Development Officer | -403,00 | 3,83k | Vente | 9,50 | 94,82k | -0,42% |
| 2026-05-14 | Dr. Reshma RangwalaExec. VP, Chief Medical Officer & Head of Research | -408,00 | 3,88k | Vente | 9,50 | 56,83k | -0,71% |
| 2026-05-14 | Ms. Sohanya ChengExec. VP, Chief Commercial Officer & Head of Business Development | -324,00 | 3,08k | Vente | 9,50 | 107,94k | -0,30% |
| 2026-05-14 | Ms. Kristin AbateVP, CAO & Assistant Treasurer | -53,00 | 503,50 | Vente | 9,50 | 23,80k | -0,22% |
| 2026-05-14 | Mr. Richard A. PaulsonPresident, CEO & Director | -2,20k | 20,93k | Vente | 9,50 | 269,75k | -0,81% |
| 2026-05-14 | Mr. Michael J. ManoExec. VP, Chief Legal Officer & Secretary | -266,00 | 2,53k | Vente | 9,50 | 94,40k | -0,28% |
| 2026-04-21 | Dr. Reshma RangwalaExec. VP, Chief Medical Officer & Head of Research | -449,00 | 4,01k | Vente | 8,94 | 12,47k | -3,48% |
| 2026-03-02 | Ms. Kristin AbateVP, CAO & Assistant Treasurer | -559,00 | 5,26k | Vente | 9,41 | 22,06k | -2,47% |
| 2026-03-02 | Mr. Michael J. ManoExec. VP, Chief Legal Officer & Secretary | -3,53k | 33,18k | Vente | 9,41 | 11,29k | -23,81% |
| 2026-03-02 | Ms. Sohanya ChengExec. VP, Chief Commercial Officer & Head of Business Development | -4,60k | 43,32k | Vente | 9,41 | 20,93k | -18,03% |
| 2026-03-02 | Dr. Reshma RangwalaExec. VP, Chief Medical Officer & Head of Research | -5,07k | 47,67k | Vente | 9,41 | 12,92k | -28,17% |
| 2026-03-02 | Mr. Richard A. PaulsonPresident, CEO & Director | -12,36k | 116,31k | Vente | 9,41 | 48,51k | -20,31% |
| 2026-03-02 | Mr. Stuart PoultonExec. VP & Chief Development Officer | -5,10k | 48,00k | Vente | 9,41 | 12,01k | -29,82% |
| 2026-02-17 | Mr. Stuart PoultonExec. VP & Chief Development Officer | -378,00 | 3,26k | Vente | 8,63 | 6,11k | -5,83% |
| 2026-02-03 | Ms. Lori A. MacomberEVP, CFO & Treasurer | -1,63k | 10,24k | Vente | 6,30 | 1,93k | -45,74% |
| 2026-01-28 | Ms. Kristin AbateVP, CAO & Assistant Treasurer | -50,00 | 351,50 | Vente | 7,03 | 22,62k | -0,22% |
| 2026-01-21 | Ms. Kristin AbateVP, CAO & Assistant Treasurer | -265,00 | 1,58k | Vente | 5,96 | 22,58k | -1,16% |
| 2025-10-01 | Ms. Kristin AbateVP, CAO & Assistant Treasurer | -362,00 | 2,28k | Vente | 6,30 | 10,05k | -3,48% |
| 2025-09-15 | Mr. Richard A. PaulsonPresident, CEO & Director | -1,26k | 8,08k | Vente | 6,43 | 33,95k | -3,57% |
| 2025-09-15 | Mr. Michael J. ManoExec. VP, Chief Legal Officer & Secretary | -234,00 | 1,50k | Vente | 6,43 | 6,70k | -3,37% |
| 2025-09-15 | Mr. Stuart PoultonExec. VP & Chief Development Officer | -401,00 | 2,58k | Vente | 6,43 | 6,49k | -5,82% |
| 2025-09-15 | Dr. Reshma RangwalaExec. VP, Chief Medical Officer & Head of Research | -408,00 | 2,62k | Vente | 6,43 | 7,24k | -5,33% |
| 2025-09-15 | Ms. Sohanya ChengExec. VP, Chief Commercial Officer & Head of Business Development | -325,00 | 2,09k | Vente | 6,43 | 13,39k | -2,37% |
| 2025-09-15 | Ms. Kristin AbateVP, CAO & Assistant Treasurer | -23,00 | 147,89 | Vente | 6,43 | 10,41k | -0,22% |
| 2025-09-03 | Ms. Kristin AbateVP, CAO & Assistant Treasurer | -12,00 | 81,36 | Vente | 6,78 | 9,46k | -0,13% |
| 2025-07-29 | Mr. Stuart PoultonExec. VP & Chief Development Officer | -191,00 | 834,67 | Vente | 4,37 | 27,22k | -0,70% |
| 2025-07-22 | Ms. Kristin AbateVP, CAO & Assistant Treasurer | -238,00 | 952,00 | Vente | 4,00 | 9,48k | -2,45% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
